| Anti-Angiogenic Activity of Curcumin in Cancer Therapy: A Narrative Review |
14 |
| Klotho-FGF Cardiovascular Disease, and Vascular Calcification: Black or White? |
13 |
| Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk |
13 |
| High-density Lipoprotein (HDL) Dysfunction and the Future of HDL |
12 |
| The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia |
10 |
| Menopausal Hormone Therapy and Cardiovascular Risk: Where are We Now? |
10 |
| Cardiovascular Risk in Psoriasis: Current State of the Art |
9 |
| Pleiotropic Effects of Statins: Untapped Potential for Statin Pharmacotherapy |
9 |
| Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation Metabolic Syndrome? |
8 |
| Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular Risk |
7 |
| Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians? |
7 |
| Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study |
7 |
| Ultrasound-Assisted Catheter-Directed Thrombolysis in High-Risk and Intermediate-High-Risk Pulmonary Embolism: A Meta-Analysis |
7 |
| Is there an Association Between Periodontitis and Atherosclerosis in Adults? A Systematic Review |
7 |
| Pharmacological Therapy of Abdominal Aortic Aneurysm: An Update |
7 |
| Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta-Analysis of Randomized Trials |
6 |
| Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients |
6 |
| Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy |
6 |
| Endothelial Extracellular Vesicles Produced by Senescent Cells: Pathophysiological Role in the Cardiovascular Disease Associated with all Types of Diabetes Mellitus |
6 |
| Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text |
6 |
| Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis |
5 |
| Platelet-Derived Exosomes Affect the Proliferation and Migration of Human Umbilical Vein Endothelial Cells via miR-126 |
5 |
| Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives |
5 |
| Vitamin D Levels in Middle-Aged Patients with Obstructive Sleep Apnoea Syndrorme |
5 |
| Insulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications |
4 |
| Involvement of Intracellular pH in Vascular Insulin Resistance |
4 |
| Insulin Therapy in Pregnancy Hypertensive Diseases and its Effect on the Offspring and Mother Later in Life |
4 |
| Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment |
4 |
| Premature Ovarian Insufficiency and Long-Term Health Consequences |
4 |
| Hypertension and Heart Failure with Preserved Ejection Fraction: Connecting the Dots |
4 |
| Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension |
3 |
| Association between Apolipoproteins AI and B and Ultrasound Indicators Carotid Atherosclerosis |
3 |
| Diabetes in Menopause: Risks and Management |
3 |
| Cardiovascular Risk in Perimenopausal Women |
3 |
| Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement |
3 |
| Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis |
3 |
| The Socioeconomic Effects of Uncontrolled Hypertension |
3 |
| Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications |
3 |
| NAFLD-NASH: An Under-Recognized Epidemic |
3 |
| Maternal Dyslipidaemia in Pregnancy with Gestational Diabetes Mellitus: Possible Impact on Foetoplacental Vascular Function and Lipoproteins in the Neonatal Circulation |
3 |
| Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall |
3 |
| Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add? |
3 |
| Renal Dysfunction Following Elective Endovascular Aortic Aneurysm Repair |
2 |
| Paraoxonase-1: Characteristics and Role in Atherosclerosis and Carotid Artery Disease |
2 |
| Pharmacological Neuroprotection in Cardiac Surgery: Effectiveness of Pharmacologic-Preconditioning with Erythromycin |
2 |
| Aortic Stenosis, Aortic Regurgitation and Arterial Hypertension |
2 |
| Associations between Adiponectin Gene Variability, Pro-inflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus? |
2 |
| Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine |
2 |
| Therapy of Cardiac Arrhythmias in Children: An Emerging Role of Electroanatomical Mapping Systems |
2 |
| Oxidative Stress and Inflammation: Their Role in the Pathogenesis of Peripheral Artery Disease with or without Type 2 Diabetes Mellitus |
2 |
